Charles River Labs declared itself surprised at the low level of demand for its China CRO services. The company opened its lab in October 2008 and, almost immediately after, it was said to be looking for a second site. However, the amount of activity in its Shanghai facility has always been less than the company’s expectations. Despite the slow start, Charles River remains positive on China’s longer-term prospects, and it feels it must be in China now to take advantage of China’s future growth. More details...

Stock Symbol: (NYSE: CRL)